We aimed toinvestigate the relationship between thyroid volume and baseline serum vitamin D status in newly diagnosed GD patients.Methods: This was a single-center cross-sectional study with a total of 61 new-onset GD patients (n=61, F: 40, M: 21) who weredivided into two groups, according to baseline serum vitamin D levels, as Group-1 (vitamin D
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: Serum vitamin D is shown to be decreased and associated with higher thyroid volumes in Graves disease (GD).
📊
Key Findings & Data:Objective: Serum vitamin D is shown to be decreased and associated with higher thyroid volumes in Graves disease (GD).
💡
Conclusion & Impact:We aimed toinvestigate the relationship between thyroid volume and baseline serum vitamin D status in newly diagnosed GD patients.Methods: This was a single-center cross-sectional study with a total of 61 new-onset GD patients (n=61, F: 40, M: 21) who weredivided into two groups, according to baseline serum vitamin D levels, as Group-1 (vitamin D
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objective: Serum vitamin D is shown to be decreased and associated with higher thyroid volumes in Graves disease (GD). We aimed toinvestigate the relationship between thyroid volume and baseline serum vitamin D status in newly diagnosed GD patients.Methods: This was a single-center cross-sectional study with a total of 61 new-onset GD patients (n=61, F: 40, M: 21) who weredivided into two groups, according to baseline serum vitamin D levels, as Group-1 (vitamin D
🔖
Cite This Article
YALIN, G. Y., YALIN, S. F., CENİK, F., ÇELİK, H. (2022). Relationship between Thyroid Volume and Baseline Vitamin D Levels in New-Onset Graves Disease. European Journal of Therapeutics, Cilt: 24 - Sayı: 3, 173–177. https://ajindex.com/articles/512334
Bizzaro G, Shoenfeld Y. Vitamin D and autoimmune thyroid diseases: facts and unresolved questions. Immunol Res 2015; 61: 46-52.
Vondra K, Starka L, Hampl R. Vitamin D and Thyroid Diseases. Physiol Res 2015; 64: 95-100.
Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Danko K et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 2011; 8: 243-7.
Kurylowicz A, Ramos-Lopez E, Bednarczuk T, Badenhoop K. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves’ disease and the vitamin D status in a Polish population study. Exp Clin Endocrinol 2006; 114: 329-35.
Abd el Gawad SS, Samee Er Abdul, Metwali AA, Abd el Gawad MS. Vitamin D receptor gene polymorphism and its association with 1,25-dihydroxyvitamin D in patients with Graves disease in an Egyptian population: a pilot study. Endocr Pract 2012; 18: 132-9.
Ramos-Lopez E, Kurylowicz A, Bednarczuk T, Paunkovic J, Seidl C, Badenhoop K. Vitamin D receptor polymorphisms are associated with Graves’ disease in German and Polish but not in Serbian patients. Thyroid 2015; 15: 1125-30.
Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease. Endocrine 2012; 42: 739-41.
Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F, et al. Serum vitamin D levels are decreased in patients without remission of Graves’ disease. Endocrine 2013; 43: 230-2. Hollick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
Shabana W, Peeters E, De Maeseneer M. Measuring thyroid gland volume: should we change the correction factor? AJR Am J Roentgenol 2006; 186: 234-6.
Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res 2014; 7: 69-87. Bouillon R. Vitamin D: from photosynthesis, metabolism and action to clinical applications. In: Endocrinology, Jameson JL, De Groot LJ, Saunders Elsevier, Philadelphia 2010.
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010; 10: 482-96.
Li YB, Xue XH, Liu SW, Xi GX, Zhao LX, Zhang XL. Clinical research of serum vitamin D in early Graves disease. Chin Rem Clin 2014; 14: 242-3.
Miao W, Ma J, Guo R, Wang YJ, Wang G, Guan HX. Research about the correlation between Serum 25(OH)D with Graves’ disease. Chin. J Pract Internal Med 2013; 33: 394-95.
Fournier C, Gepner P, Sadouk M. In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvit